Table 5 Outcomes of the cohort analysis
Variables | All patients (n = 73) | Pre-VAD DPG < 7 (n = 49, 67.1%) | Pre-VAD DPG ≥ 7 (n = 24, 32.9%) | P value |
|---|---|---|---|---|
RVF (n, %) | 24 (32.9) | 3 (6.1) | 21 (87.5) |  < 0.001 |
RVAD insertion (n, %) | 13 (17.8) | 2 (4.1) | 11 (45.8) |  < 0.001 |
AKI (n, %) | 43 (58.9) | 21 (42.9) | 22 (91.7) |  < 0.001 |
Need for CRRT (n, %) | 20 (27.4) | 8 (16.3) | 12 (50) | 0.002 |
Exploration for bleeding (n, %) | 13 (17.8) | 6 (12.2) | 7 (29.2) | 0.11 |
Cerebrovascular stroke (n, %) | 6 (8.2) | 3 (6.1) | 3 (12.5) | 0.39 |
Tracheostomy (n, %) | 12 (16.4) | 7 (14.3) | 5 (20.8) | 0.51 |
ICU days | 9 (8–16) | 9 (8–16) | 24 (15–42.5) | 0.001 |
Milrinone days | 4 (3–6) | 4 (3–6) | 13 (6–16) |  < 0.001 |
Inhaled NO days | 3 (2–4) | 3 (2–4) | 9.5 (4.5–14.5) |  < 0.001 |
Ventilator days | 2 (1–3) | 2 (1–3) | 6.5 (3–26) |  < 0.001 |
Septicemia (n, %) | 9 (12.3) | 4 (8.2) | 5 (20.8) | 0.14 |
Total mortality (n, %) | 24 (32.9) | 13 (26.5) | 11 (45.8) | 0.036 |
On-VAD mortality (n, %) | 18 (24.7) | 10 (20.4) | 8 (33.3) | 0.04 |
Transplantation (n, %) | 17 (23.3) | 10 (20.4) | 7 (29.2) | 0.41 |
Mortality after transplantation (n, %) | 6 (35.3) | 3 (30) | 3 (42.9) | 0.64 |